Home > Products > CD16 & CD30
> Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab)
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-034)
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (CrossMab) (CROSSAB-034). Click the button below to contact us or submit your feedback about this product.